Richard Kaschula

Richard Kaschula is currently the Principal at NG Bio, a venture investor focused on early-stage therapeutic opportunities in autoimmune and chronic inflammatory diseases. Prior to their current role, Richard served as a Venture Builder at LifeArc and as a Technology Transfer Fellow at The Francis Crick Institute. Richard holds a PhD in Biology/Biological Sciences, an MFin in Finance, an MSc in Cell and Developmental Biology, and a BSc in Biological and Medicinal Chemistry.